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Abstract
Principal component analysis (PCA) has been widely used to visualize high-
dimensional metabolomic data in a two- or three-dimensional subspace. In metabolomics,
some metabolites (e.g. top 10 metabolites) have been subjectively selected when
using factor loading in PCA, and biological inferences for these metabolites are
made. However, this approach is possible to lead biased biological inferences be-
cause these metabolites are not objectively selected by statistical criterion. We
proposed a statistical procedure to pick up metabolites by statistical hypothesis
test of factor loading in PCA and make biological inferences by metabolite set
enrichment analysis (MSEA) for these significant metabolites. This procedure
depends on the fact that the eigenvector in PCA for autoscaled data is propor-
tional to the correlation coefficient between PC score and each metabolite levels.
We applied this approach for two metabolomic data of mice liver samples. 136
of 282 metabolites in first case study and 66 of 275 metabolites in second case
study were statistically significant. This result suggests that to set the previously-
determined number of metabolites is not appropriate because the number of sig-
nificant metabolites is different in each study when using factor loading in PCA.
Moreover, MSEA was performed for these significant metabolites and significant
metabolic pathways can be detected. These results are acceptable when compared
with previous biological knowledge. It is essential to select metabolites statisti-
cally for making unbiased biological inferences from metabolome data, when us-
ing factor loading in PCA. We proposed a statistical procedure to pick up metabo-
lites by statistical hypothesis test of factor loading in PCA and make biological
inferences by MSEA for these significant metabolites. We developed an R pack-
age ”mseapca” to perform this approach. The “mseapca” package is publicity
available on CRAN website.
Background 
 Metabolomics is a science based on exhaustive-profiling of metabolites. In 
metabolomics, various analytical technologies such as capillary 
electrophoresis–mass spectrometry (CE–MS), liquid chromatography–mass 
spectrometry (LC–MS), gas chromatography–mass spectrometry (GC–MS) and 
nuclear magnetic resonance (NMR) etc. have been used. Statistical analysis for 
these analytical data has been studied in chemometrics research area [1]. In 
metabolomics, chemometrics approaches commercing with multivariate analysis 
such as principal component analysis (PCA) have been mainly applied. 
  PCA [2] has been routinely used to visualize high-dimensional metabolomic data 
in two- or three-dimensional subspace in metabolomics as well as a heat map in 
transcriptmics. A scatter plot of PC score vectors (a score plot) can be used for 
outlier detection or discovering biologically interpretable patterns. Typically, 
upon finding a specific PC score is related to a phenotype of interest [3, 4], such 
as time course or group information, the corresponding factor loading has been 
evaluated to discover meaningful metabolites for making biological inferences. 
In many metabolomics research articles [5, 6, 7], an eigenvector in PCA (eq. 1) 
has been used as factor loading. For making biological inferences, some 
metabolites (e.g. top 10 metabolites) has been subjectively selected by using the 
eigenvector. However, this approach has some problems. For example, many 
metabolites varies with phenotype in a study and only a few metabolites in 
another study. An existing approach using the eigenvector equals to set the same 
number of metabolites for making biological inferences among these different 
studies. As a result, biological interpretation might be performed by using not 
significant metabolites varied with phenotype irrelevantly. Additionally, the value 
of eigenvector itself does not have statistical sense because it is nothing but 
normalized that the sum of squares is 1 just for computational reason.  
The eigenvectors in PCA for autoscaled data [8] are proportional to correlation 
coefficient between PC scores and variables. This fact is well-known in 
multivariate analysis literature [9] but appears not to be appreciated in 
metabolomics. In the present study, factor loading was defined as correlation 
coefficient between PC scores and variables. This definition can be used to 
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perform statistical hypothesis testing and can select significant metabolites 
objectively by statistical criteria.  
Significant metabolites are selected in some way and afterward biological 
inferences are made for these metabolites by biologists. They often make 
biological inferences with respect to a biological functional unit such as metabolic 
pathway (e.g. “glycolysis is notably activated” or “an amino acid metabolism is 
significantly suppressed”). In gene expression analysis, gene set enrichment 
analysis (GSEA) has been applied to find significant gene sets by using gene 
ontology (GO) terms. In metabolomics, metabolite set enrichment analysis 
(MSEA) [10] can find significant metabolic pathway. MSEA has been computed 
by some approaches such as over representation analysis (ORA) [11], 
Subramanian’s GSEA [12] and global test [13]. MSEA is convenience to make 
biological inferences from metabolomic data, but this approach has not been 
applied for metabolites selected by factor loading in PCA. 
In the present study, we performed statistical hypothesis test of factor loading 
in PCA for two metabolomic data sets of mice liver samples as case studies. This 
approach can select significant metabolites when using factor loading in PCA, and 
MSEA by ORA approach can be applied for these significant metabolites. We 
developed the R package ‘mseapca’ to work sequence from statistical hypothesis 
test of factor loading in PCA to MSEA. 
 
Theory 
Principal Component Analysis (PCA) 
Consider a mean-centered data matrix X that has samples in each row and 
variables in each column. A score vector is related to the data matrix by t = Xw 
where w is a vector of weights. PCA is formulated as the optimization problem of 
maximizing the variance of the score vector t:  
1
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and the weight vector w is often used for factor loading. After a transformation, eq. 
(1-1) can be rewritten as the eigenvalue problem 
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An eigenvector w and eigenvalue λ of eq. (1-2) can be computed by using 
numerical computation libraries for singular value decomposition. An eigenvalue 
λ corresponds to the variance of the PC score vector formed using the associated 
eigenvector as the weight vector. 
A coefficient of the correlation between the PC score and the p-th variable can 
be defined as  
)var()var(
1/),(corr
p
n
xt
xt'
xt pp
−
=
 
(1-3)
 
where t'
 
is the transpose of t. Introducing c as the column vector in which the p-th 
element is 1 and the others are 0, so that xp = Xc, we have 
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Transposing eq. (1-2) gives 'n wXXw λ=−1/''  which can be substituted in eq. 
(1-4), giving 
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Then the variance of the score vector can be replaced by λ and the standard 
deviation of xp is replaced by σp. Finally, the correlation between PC score and 
variables can be written as 
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With data scaled to unit variance (autoscaling), the weight wp is proportional to 
the correlation coefficient between the PC score and variable xp because σp = 1 in 
eq. (1-6). Thus, the factor loading can be defined as the correlation coefficient in 
eq. (1.6). On the basis of this definition, we can perform a statistical test for factor 
loading in PCA, using the well-known fact that, for a correlation coefficient r, the 
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has a t-distribution with (n-2) degrees of freedom. Then, we can select variables 
that have a statistically significant correlation with the PC score and make 
biological inferences using these variables. 
 
Materials and Methods 
Sample preparation, metabolome analysis and data processing 
BKS.Cg-m+/m+/Jcl (normal mice), 12-h fasting normal mice, 
BKS.C-+Leprdb/+Leprdb/Jcl (db/db mice) and db/db mice orally administered 
pioglitazone for 10 days were used. The mice were seven-week-old males with 
unlimited access to food and water except for those on the 12-h fasting. The 
concentration of administered pioglitazone was 100 mg/10 mL/kg. The 
pioglitazone was purchased from Takeda Pharmaceutical Co. ltd, and purified by 
NARD Institute Ltd. After sampling, the livers were excised and stored at –80 ℃. 
From purchase and breeding of the mice to collection of liver samples, all 
experiments were performed at the Kitayama Labs Co. Ltd. The sample 
preparation procedure to extract metabolites was that described by Ooga et al 
[14].  
The metabolite extracts were measured by capillary electrophoresis 
time-of-flight mass spectrometry (CE-TOFMS). CE-TOFMS was carried out 
using Agilent Capillary Electrophoresis Systems equipped with an Agilent 6210 
time-of-flight mass spectrometer, an Agilent 1100 isocratic HPLC pump, an 
Agilent G1603A CE-MS adapter kit and an Agilent G1607A CE-ESI-MS sprayer 
kit (Agilent Technologies, Waldbronn, Germany). The system was controlled by 
G2201AA ChemStation Software version B.03.01 for CE (Agilent Technologies, 
Waldbronn, Germany). Modified analytical methods for the measurement of 
cationic [15] and anionic metabolites [16] were used. Measurement data were 
processed by peak processing software [17]. Signal peaks corresponding to 
isotopomers, adduct ions and other product ions of known metabolites were 
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excluded. Then all signal peaks potentially corresponding to authentic compounds 
were extracted, and their migration time (MT) was normalized using those of the 
internal standards (methionine sulfone and CSA for cations and anions, 
respectively). Thereafter, the alignment of peaks was performed according to the 
m/z values and normalized MT values. Finally, peak areas are normalized against 
those of the internal standards. The resultant relative area values were further 
normalized by the sample weight. Annotation tables were produced from 
CE-TOFMS measurements of standard compounds, and were aligned with 
datasets according to similar m/z values and normalized MT values. 
 
Statistical Analysis 
In the present study, all computation were performed by R [18] and “mseapca” 
[19] package. A missing value was imputed to 0 for a computation of PCA. A 
metabolite set list was created by referring to KEGG [20], and partial 
modification was performed by manual curation. The xml file of metabolite set 
list used in this study is included in “mseapca” package.  
 
Software 
An R package “mseapca” [19] consists of three major features. The first 
one is to create a list of metabolic pathway. A “csv2list“ function converts your 
own csv file in which first column is name of metabolic pathway and second 
column is metabolite IDs to list format in R. A “pathway_class” function converts 
KEGG’s tar.gz files (e.g. hsa.tar.gz in Homo sapience) to list format of metabolic 
pathway. The KEGG’s tar.gz files can be downloaded from KEGG FTP according 
to your own license. A “list2xml” function converts list format of metabolic 
pathway to xml format. This xml format can be saved as xml file by 
using ”saveXML” function in “XML” package. A ”read_pathway” function can 
read the created xml file and convert to list of metabolic pathway for a 
computation of MSEA. 
The second one is a “pca_scaled” function to perform PCA. In this 
function, data matrix is automatically scaled to zero mean and unit variance 
(autoscaling) for each metabolites. PC scores, factor loadings and p-value and 
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q-value by Benjamini and Hochberg [21] as the results of statistical hypothesis 
test of factor loading are returned. In this function, factor loading is defined as a 
correlation coefficient between PC score and each metabolite levels. 
The third one is to perform MSEA. A “msea_ora” function can perform 
MSEA by over representation analysis (ORA) [11]. In this function, statistical 
hypothesis test of cross tabulation is performed by one-sided Fisher’s exact test. A 
“msea_sub” function performs MSEA implemented in the same fashion as GSEA 
by Subramanian et al. In this function, a permutation procedure is performed for a 
metabolite set rather than class label. This procedure corresponds to “gene set” of 
permutation type in GSEA-P software [22]. A leading-edge subset analysis is also 
undertaken following the GSEA procedure [21].  
An R package “mseapca” can be freely available from CRAN web site 
[19]. For details, see the reference manual in CRAN web site of "mseapca" [19] 
for more information. 
 
4. Results 
4.1. Case study 1: a comparative study of control and 12-h fasting mice 
We describe the utilization of statistical hypothesis test of factor loading in 
PCA by using metabolome data in two studies. First case study is a comparative 
study of normal and 12 hour fasting mouse. 5 liver samples each for control and 
12 hour fasting mice were used for metabolome analysis. As a result, 282 
metabolites were identified. 
PCA was performed for this metabolome data preprocessed by autoscaling. 
The score plot of PCA (Fig. 1 (A)) showed that the PC1 score of control and 
fasting mice were negative and positive, respectively. This result suggests that the 
PC1 score was positively related to fasting effect. In this case, metabolites which 
have large positive factor loading in PC1 tended to increase and negative factor 
loading tended to decreased with 12 hour fasting. 
Statistical hypothesis test for factor loading in PC1 was performed, and 
136 metabolites were statistically significant under p<0.05 (Supplementary 
Table1). MSEA by ORA for factor loading was performed for positive and 
negatively significant metabolites independently (Table1). The purine metabolism 
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was significantly activated in 12 hour fasting mice under p<0.05. Glycolysis was 
significantly suppressed under q<0.05 and pentose phospate pathway, TCA cycle, 
cystein metabolism and polyamine metabolism were significantly suprressed in 12 
hour fasting under p<0.05. MSEA by Subramanian et al. was also performed as a 
reference (Table1). The histidine metabolism and purine metabolism having 
negative normalized enrichment score (NES) were significantly activated in 12 
hour fasting mice under p<0.05. Glycolysis having positive NES was significantly 
suppressed under q<0.05 and pentose phospate pathway, TCA cycle and 
polyamine metabolism were significantly suppressed in 12 hour fasting under 
p<0.05. These results suggest that the results of these two MSEA approaches are 
largely consistence. 
The results of MSEA for factor loading in PC1 suggested that the process 
of energy metabolism, such as glycolysis and the TCA cycle, were decreased by 
12 hour fasting. The suppression of these metabolic pathway suggests that 
glycogen is drained and glucose supplementation is restricted in mouse liver 
under the condition of fasting 12 hour. And, body weight was 22.20±0.84 
(mean±SD) in normal mouse and 20.0±0.71 in 12 hour fasting mouse, and 
statistically significant decreased (p=0.0021) during 12 hour fasting by Welch’s 
t-test. This result shows that the suppression of energy metabolism might result in 
a decrease of body weight. 
 
4.2. Case study 2: a comparative study between diabetes model mice without and 
with administered pioglitazone 
The db/db mouse is a model of obesity, diabetes and dyslipidemia in which 
leptin receptor activity is deficient because the mice are homozygous for a point 
mutation in the leptin receptor gene [23]. Pioglitazone reduces insulin resistance 
in the liver and decreases glucose level in the blood [24, 25]. Hence, it is used for 
the treatment of diabetes. 
We compared the metabolome data of mouse liver samples from db/db mice 
with and without pioglitazone in order to examine the effect of administering 
pioglitazone to db/db mice. 5 liver samples each for db/db mice and db/db with 
Hosted by The Berkeley Electronic Press
administering pioglitazone were used for metabolome analysis. As a result, 275 
metabolites were identified. 
We performed PCA on data preprocessed by autoscaling in a comparative 
study of db/db mice with and without administered pioglitazone. The score plot is 
shown in Fig. 5. A perfect separation between groups could be achieved on the 
first PC axis (Fig. 3), and thus we focused on this axis. The PC1 score of the 
db/db mice with and without administered pioglitazone showed positive and 
negative value, respectively, suggesting that PC1 score is positively related to the 
effect of the administration of pioglitazone.  
Statistical hypothesis test for factor loading in PC1 was performed, and 66 
metabolites were statistically significant under p<0.05. MSEA for factor loading 
was performed as well as the previous section (Table2). In both MSEA by ORA 
and Subramanian’s approach, glycolysis was only statistically significant 
activated by administered pioglitazone under p<0.05. Pioglitazone is a 
peroxisome proliferator-activated receptor (PPAR) activating agent. Lee et al. 
[26] suggested that PPARδ ameliorated hyperglycemia by increasing glucose flux 
through the regulation of gene expression. And administering pioglitazone was 
known to reduce the glucose level in blood [24, 25].  
In the present study, glucose blood level was 369.6±64.8 (mean±SD) in db/db 
mouse and 332.8±131.9 in db/db mice with administered pioglitazone. The 
change of glucose blood level was not significantly decreased (p=0.596) by 
administered pioglitazone by Welch’s t-test. This result suggests that metabolome 
analysis could detect the subtle change caused by administering pioglitazone in 
glycolysis pathway. 
 
Discussion 
Metabolite selection by statistical hypothesis test of factor loading in PCA 
has some advantages. This approach was applied for metabolome data in two case 
studies of mouse liver samples. 136 of 282 metabolites were significantly 
correlated with PC1 score associated with groups in first case study and 66 of 275 
metabolites in second study. The number of significant metabolites is twice larger 
in first case study than in second case study. This result suggests that to set the 
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previously-determined number of metabolites (e.g. top 10 metabolites) is not 
appropriate because the number of significant metabolites is different in each 
studies. Additionally, we note the relationship between contribution ratio and the 
number of significant metabolites for factor loading in PCA. The ratio of the 
number of significant metabolites to all detected metabolites is 0.482 (=136/282) 
in first case study and 0.24 (=66/275) in second case study. The contribution ratio 
in PC1 is 40.5% in first case study and 24.2% in second case study. This result 
suggests that an implicit relationship between contribution ratio and the number of 
significant metabolites under same sample size. 
In both two case studies, we focused on PC1 (Fig.1 and Fig.2) which 
shows difference between groups. Then, we compared this approach with 
ordinary statistical hypothesis test such as t-test. 122 metabolites were significant 
in first case study and 56 metabolites were significant in second case study by 
Welch’s t-test. As compared with metabolites picked up by statistical test of factor 
loading, 112 metabolites and 47 metabolites shared in each study. The fact that 
most significant metabolites shared between two approaches suggests that 
statistical test of factor loading in PCA can be readily used to pick up metabolites 
as a special case of two-sample test when a difference between groups appears in 
PC score. On the other hand, in metabolomics, complex studies such as a 
fermentation process by microorganism [27] having various time points or groups 
and drug administration having various concentration in various condition [28]. 
Statistical test for factor loading in PCA can be widely used not only two-sample 
study but also various studies when PC score associated with phenotype can be 
found.  
MSEA was performed for significant metabolites and acceptable 
biological inferences were given in two case studies. In conventional approach, 
previously-determined number of metabolite (e.g. 10 metabolites) has been 
subjectively selected for making biological inferences. According to this approach, 
MSEA was performed for the top 10 metabolites having large negative factor 
loading in first case study. No significant metabolic pathway was detected under 
p<0.05 (data not shown). In this case, only 10 metabolites were too small for 
making acceptable biological inferences. Even if significant metabolic pathways 
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were detected by MSEA for not significant metabolites, it is doubtful whether 
these significant metabolic pathways are meaningful statistically and biologically. 
To make unbiased biological inferences by using statistical analysis, significant 
metabolites should be selected by using statistical test of factor loading when 
using in PCA. 
 In the present study, two MSEA approaches of ORA and Subramanian’s 
approach were performed. As a way of utilizing factor loading for GSEA, Rudolf 
S. N. Fehrmann et al. [29] named the PC score associated with phenotype as 
transcriptional system regulators (TSR) score, and factor loading corresponding to 
TSR score was used for GSEA by Subramanian’s approach. This directly uses the 
factor loading but does not use the result of statistical hypothesis test of factor 
loading. As far as we know, an approach combining GSEA or MSEA with the 
result of statistical hypothesis test of factor loading in PCA has not been reported. 
The result of both MSEA of ORA and Subramanian’s approach has almost 
same results in two case studies. In a comparison of computational time between 
two MSEA approaches, it cost 441.43 seconds by Subramanian’s approach and 
0.83 seconds by ORA in first case study. This result showed that MSEA of ORA 
has an advantage about computational cost. Conventionally, PCA and MSEA can 
be computed in different step or software independently. There has not been 
software which can compute as sequence from PCA and statistical hypothesis test 
of factor loading to MSEA. Therefore, we developed an R package “mseapca” to 
work sequence from statistical hypothesis test of factor loading in PCA to MSEA. 
 
Conclusion 
In metabolomics, targeted metabolites for making biological inferences 
were subjectively selected when using factor loading in PCA. We proposed a 
statistical procedure to pick up metabolites by statistical hypothesis test of factor 
loading in PCA, and these significant metabolites was used to find significant 
metabolic pathway by MSEA. We applied this approach to two metabolomic data 
of mouse liver samples, and acceptable results were given when compared with 
previous biological knowledge. We developed an R package “mseapca” to 
examine our approach readily. There are many users of PCA in metabolomics. 
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Our approach can improve an existing use of PCA and is expected to be widely 
applied. 
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Figures 
 
Fig. 1. Result of PCA in a comparative study of normal and 12-h fasting mice. (A) 
Score plot of PC1 and PC2. Symbols: (○) control mouse; (●) 12-h fasting mouse. 
(B) Factor loading plot in PC1. Metabolites are sorted in ascending order of the 
value of factor loading. The dotted line shows the significant level under p<0.05. 
 
Fig. 2. Result of PCA in a comparative study of diabetes model mice with and 
without administered pioglitazone. (A) Score plot of PC1 and PC2. Symbols: (○) 
diabetes model mouse (db/db mouse) without administered pioglitazone; (●) 
db/db mouse with administered pioglitazone. (B) Factor loading plot in PC1. 
Metabolites are sorted in ascending order of the value of factor loading. The 
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dotted line shows the significant level under p<0.05. The dotted line shows 
significant level under p<0.05. 
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